Radovich Peter
SEC CIK 1650131 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MIRM | Mirum Pharmaceuticals, Inc. | Pres AND COO | 57.3K | — | $3.99M | 30 | 2021-09-29 | 2026-06-05 |
Most active insiders at MIRM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Peetz Christopher | CEO, Dir | — | $16.29M |
| 2 | GREY MICHAEL G | Dir | — | $11.10M |
| 3 | Heron Patrick J | Dir | $9.00M | — |
| 4 | Howe Jolanda | SVP, Gbl Ctrl | — | $5.55M |
| 5 | BJERKHOLT ERIC | CFO | — | $3.56M |
| 6 | Radovich Peter | Pres AND COO | — | $2.32M |
| 7 | Ramasastry Saira | Dir | — | $1.92M |
| 8 | Quan Joanne | Chief MEDICAL Off | — | $1.46M |
| 9 | Cardon Lon | Dir | — | — |
| 10 | Fischer Laurent | Dir | — | — |
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-08 16:27 | 2026-06-05 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres AND COO | M - OptEx | $19.19 | +17.0K | 57.3K | +42% | +$326.0K |
| DM | 2026-03-17 | 2026-03-15 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres AND COO | M - OptEx | — | +30.2K | 33.8K | +847% | — |
| D | 2026-03-17 | 2026-03-16 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres AND COO | S - Sale+OE | $91.98 | -16.5K | 40.3K | -29% | -$1.52M |
| D | 2026-03-11 | 2026-03-06 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres AND COO | M - OptEx | $15.87 | +5,912 | 26.6K | +29% | +$93.8K |
| 2026-02-03 | 2026-02-02 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres AND COO | S - Sale | $103.30 | -2,631 | 20.7K | -11% | -$271.8K | |
| D | 2026-01-27 | 2026-01-26 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres AND COO | S - Sale+OE | $96.19 | -3,143 | 23.3K | -12% | -$302.3K |
| D | 2026-01-27 | 2026-01-23 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres AND COO | M - OptEx | — | +5,750 | 26.4K | +28% | — |
| D | 2026-01-23 | 2026-01-22 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres AND COO | S - Sale+OE | $93.33 | -2,382 | 20.7K | -10% | -$222.3K |
| D | 2026-01-23 | 2026-01-21 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres AND COO | M - OptEx | — | +4,167 | 23.1K | +22% | — |
| D | 2025-03-18 | 2025-03-17 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres AND COO | S - Sale+OE | $44.21 | -7,879 | 18.7K | -30% | -$348.3K |
| D | 2025-03-18 | 2025-03-15 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres AND COO | M - OptEx | — | +14.4K | 26.6K | +119% | — |
| M | 2025-03-05 | 2025-03-04 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres AND COO | S - Sale | $45.58 | -14.8K | 12.1K | -55% | -$676.9K |
| 2025-02-04 | 2025-02-03 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres AND COO | S - Sale | $48.22 | -2,627 | 27.0K | -9% | -$126.7K | |
| D | 2025-01-27 | 2025-01-24 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres AND COO | S - Sale+OE | $47.92 | -3,177 | 29.6K | -10% | -$152.2K |
| D | 2025-01-27 | 2025-01-23 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres AND COO | M - OptEx | — | +5,750 | 32.8K | +21% | — |
| 2025-01-08 | 2025-01-07 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres AND COO | S - Sale | $42.82 | -1,998 | 27.0K | -7% | -$85.6K | |
| 2024-03-25 | 2024-03-25 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres AND COO | S - Sale | $25.80 | -4,303 | 29.0K | -13% | -$111.0K | |
| 2024-03-18 | 2023-01-09 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres AND COO | S - Sale | $20.62 | -1,379 | 33.3K | -4% | -$28.4K | |
| 2024-02-05 | 2024-02-02 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | Pres AND COO | S - Sale | $26.19 | -1,790 | 34.7K | -5% | -$46.9K | |
| 2024-01-09 | 2024-01-08 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | COO | S - Sale | $28.03 | -1,408 | 36.5K | -4% | -$39.5K | |
| 2023-11-15 | 2023-11-10 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | COO | A - Grant | $22.29 | +218 | 37.9K | +0.6% | +$4,859 | |
| 2023-07-05 | 2023-07-03 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | COO | S - Sale | $25.65 | -1,425 | 37.7K | -4% | -$36.6K | |
| 2023-05-19 | 2023-05-10 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | COO | A - Grant | $16.92 | +968 | 39.1K | +3% | +$16.4K | |
| D | 2023-02-02 | 2023-01-31 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | COO | A - Grant | $0.00 | +14.4K | 38.1K | +61% | $0 |
| 2022-11-14 | 2022-11-10 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | COO | A - Grant | $17.05 | +292 | 23.7K | +1% | +$4,979 | |
| 2022-05-12 | 2022-05-10 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | COO | A - Grant | $13.57 | +1,169 | 23.4K | +5% | +$15.9K | |
| D | 2022-01-07 | 2022-01-06 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | COO | A - Grant | $0.00 | +10.0K | 22.2K | +82% | $0 |
| 2021-11-15 | 2021-11-10 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | COO | A - Grant | $13.52 | +958 | 12.2K | +8% | +$13.0K | |
| 2021-10-01 | 2021-10-01 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | COO | S - Sale | $19.26 | -1,364 | 11.3K | -11% | -$26.3K | |
| 2021-10-01 | 2021-09-29 | MIRM | Mirum Pharmaceuticals, Inc. | Radovich Peter | COO | A - Grant | $0.00 | +8,125 | 12.6K | +180% | $0 |
Purchase Sale Sale after option exercise All abbreviations